Fineline Cube

Follow:
14435 Articles
Sino Biopharmaceutical's TQC3302 Approved for COPD Maintenance Treatment Clinical Trials
CompanyDrug

Sino Biopharmaceutical’s TQC3302 Approved for COPD Maintenance Treatment Clinical Trials

Humanwell Healthcare Receives NMPA Approval for HW241045 IPF Clinical Trials
CompanyDrug

Humanwell Healthcare Receives NMPA Approval for HW241045 IPF Clinical Trials

Everest Medicines' Nefecon Granted Full Approval by Taiwan's TFDA for IgA Nephropathy
CompanyDrug

Everest Medicines’ Nefecon Granted Full Approval by Taiwan’s TFDA for IgA Nephropathy

CSPC Pharmaceutical's Semaglutide Injection NMPA Marketing Application Accepted
CompanyDrug

CSPC Pharmaceutical’s Semaglutide Injection NMPA Marketing Application Accepted

Hebei Senlang's SENL103 CAR-T Therapy Approved for Refractory Generalized Myasthenia Gravis in China
CompanyDrug

Hebei Senlang’s SENL103 CAR-T Therapy Approved for Refractory Generalized Myasthenia Gravis in China

ChemPartner and Leado Pharma Sign Strategic Agreement to Advance New Drug R&D
CompanyDeals

ChemPartner and Leado Pharma Sign Strategic Agreement to Advance New Drug R&D

Zhongheng Group Acquires Patent for Innovative Chronic Heart Failure Drug LZ-01
CompanyDeals

Zhongheng Group Acquires Patent for Innovative Chronic Heart Failure Drug LZ-01

Gaush Meditech's Frequency-Domain Biometer Gains Medical Device Registration in Jiangsu
CompanyMedical Device

Gaush Meditech’s Frequency-Domain Biometer Gains Medical Device Registration in Jiangsu

Sichuan Huiyu's HY05350 Achieves First Patient Dosing in Phase I Trial for MSLN-Positive Tumors
CompanyDrug

Sichuan Huiyu’s HY05350 Achieves First Patient Dosing in Phase I Trial for MSLN-Positive Tumors

Zhaoke Ophthalmology's TONO-i Gains NMPA Approval for Glaucoma Management in China
CompanyDrug

Zhaoke Ophthalmology’s TONO-i Gains NMPA Approval for Glaucoma Management in China

Kexing Partners with Guangdong Zhongsheng to Commercialize Onradivir Tablets in Macau
CompanyDeals

Kexing Partners with Guangdong Zhongsheng to Commercialize Onradivir Tablets in Macau

Innovent Biologics' IBI3032 Receives IND Approval From FDA and NMPA for GLP-1RA Clinical Trials
CompanyDrug

Innovent Biologics’ IBI3032 Receives IND Approval From FDA and NMPA for GLP-1RA Clinical Trials